Dynamic marketing leader with a robust history at Macleods Pharmaceuticals Ltd., excelling in digital marketing and strategic planning. Spearheaded innovative campaigns, driving a portfolio worth 93 crore annually, showcasing exceptional brand promotion and market analysis skills. Proven track record in enhancing customer relationships, with a notable achievement in packaging innovation for improved prescription adherence.
From April 2018 onwards Handling: Cardiac-Diabetic range of important products
Brands: Damita/M (Dapagliflozin combination) 12 Cr, Macsart Range (Telmisartan combinations) 35 Cr, Sacuhart (ARNI) 1.5 Cr, Moxovas (Moxonidine) 43 Cr, Linamac range (Linagliptin combinations) 1.7 Cr
Total Portfolio Size: 93 crore annually
Previously handled brands: Amlovas Range (Amlovas combinations) 37 Cr and Rozustat Range
(Rosuvastatin combination) 26 Cr
Total Portfolio Size: 63 crore annually
Planning a territory, determining a specific group of target customers, and putting the company's marketing tactics into practice and adhering to them. To promote pharmaceutical products to physicians, pharmacists, and stockists, and to market antibiotics, cough syrup, antispasmodics, antiulcers, NSAIDs, steroids, antivirals, V&M, and antiemetics. Weekly stock monitoring was necessary to ensure that pharmacists have enough inventory to meet demand and sales goals.